Key Highlights
- Medable AI enables rapid digital and decentralized trial setup.
- Automated study builds take minutes instead of days, enhancing trial efficiency.
- First generative AI in clinical study build, reducing First Patient In (FPI) timelines.
- Medable Studio integration for streamlined trial management and transparency.
- Available on Google Cloud Marketplace in December 2024.
Source: Business Wire
Notable Quotes
- “We are focused on step function change – true innovation, not iteration. As fast as the world is changing, this is critical, and we are starting by taking eCOA and DCT off the critical path. This is just the beginning.” — Dr. Michelle Longmire, CEO and Co-founder at Medable
- “We are proud to showcase our AI capabilities within the Medable platform and, through Studio, eliminate one of the biggest hurdles to broad adoption of digital and decentralized clinical trials.” — Tim Smith, Chief Technology Officer at Medable
SoHC's Take
Medable’s AI integration represents a significant leap in clinical trial technology. By automating complex, time-intensive tasks, Medable AI transforms the trial startup process, aiming to shift timelines from days to minutes. This innovation is particularly impactful for digital and decentralized trials, where traditional manual processes have often been bottlenecks. As the first company to integrate generative AI in this space, Medable positions itself as a frontrunner in clinical technology, offering trial sponsors a competitive edge through efficiency and control. This aligns with a broader industry shift toward greater use of AI to drive value and cost savings in clinical research.
